VEGFA and neoplasm: Several other monoclonal antibodies were soon described and tested for anti-VEGF purposes [104,105], such as inhibiting VEGF-induced endothelial cell proliferation in vitro, as well as tumor growth [106], and they were tested for their safety in clinical trials [107].